Primary Outcomes From a Phase 3, Randomized, Double-Blind, Active-Controlled Trial of Surotomycin in Subjects With Clostridium difficile Infection
暂无分享,去创建一个
R. Fedorak | K. Mullane | U. Stoutenburgh | M. Jin | A. Adedoyin | L. Chesnel | D. Guris | K. Larson | Y. Murata | V. Boix | Y. Pesant
[1] T. Louie,et al. Surotomycin versus vancomycin for Clostridium difficile infection: Phase 2, randomized, controlled, double-blind, non-inferiority, multicentre trial. , 2016, The Journal of antimicrobial chemotherapy.
[2] O. Dekkers,et al. European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[3] E. Goldstein,et al. Impact of Surotomycin on the Gut Microbiota of Healthy Volunteers in a Phase 1 Clinical Trial , 2016, Antimicrobial Agents and Chemotherapy.
[4] Lisa G Winston,et al. Burden of Clostridium difficile Infection in the United States , 2015 .
[5] V. Young,et al. Clostridium difficile and the microbiota. , 2014, The Journal of clinical investigation.
[6] Kelly R. Reveles,et al. The rise in Clostridium difficile infection incidence among hospitalized adults in the United States: 2001-2010. , 2014, American journal of infection control.
[7] Fernanda C. Lessa,et al. Current Status of Clostridium difficile Infection Epidemiology , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[8] D. Snydman,et al. Activity of a Novel Cyclic Lipopeptide, CB-183,315, against Resistant Clostridium difficile and Other Gram-Positive Aerobic and Anaerobic Intestinal Pathogens , 2012, Antimicrobial Agents and Chemotherapy.
[9] K. Garey,et al. High Horn's index score predicts poor outcomes in patients with Clostridium difficile infection. , 2011, The Journal of hospital infection.
[10] Pamela Sears,et al. Fidaxomicin versus vancomycin for Clostridium difficile infection. , 2011, The New England journal of medicine.
[11] D. Gerding,et al. Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. , 2009, Gastroenterology.
[12] C. Kelly,et al. Clostridium difficile--more difficult than ever. , 2008, The New England journal of medicine.